On 2024-11-29 Global Info Research released【Global CRO in Clinical Trials Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030】. This report includes an overview of the development of the CRO in Clinical Trials industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CRO in Clinical Trials.
The global CRO in Clinical Trials market size is expected to reach $ 89680 million by 2030, rising at a market growth of 9.3% CAGR during the forecast period (2024-2030).
A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%. In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.
The market for Contract Research Organizations (CROs) in clinical trials is experiencing significant growth and evolution due to various factors:
Biopharmaceutical Companies: Many pharma and biotech firms are increasingly outsourcing clinical trials to CROs to reduce costs, improve efficiency, and tap into specialized expertise. This trend is particularly notable among smaller biotech companies with limited infrastructure.
Focus on Core Competencies: Large pharmaceutical companies prefer focusing on core R&D activities, delegating clinical trial processes to CROs for scalability and cost-effectiveness.
Decentralized Clinical Trials (DCTs): CROs are innovating with decentralized trial models, enabling remote patient monitoring and data collection. This trend has accelerated post-COVID-19, enhancing patient recruitment, retention, and trial accessibility.
Adaptive and Hybrid Trials: The need for quicker, adaptable trials that can respond to real-time data is driving hybrid and adaptive trial designs. CROs are investing in capabilities to support these complex trial models.
Expanding Trials in APAC and LATAM: CROs are increasingly establishing operations in Asia-Pacific, Latin America, and Eastern Europe, where costs are lower, and recruitment pools are larger.
Regulatory Alignment: Many countries are harmonizing their regulatory requirements with global standards, making it easier for CROs to conduct trials internationally.
Artificial Intelligence (AI) and Machine Learning (ML): CROs are adopting AI/ML for predictive modeling, patient recruitment, trial monitoring, and data analysis, increasing accuracy and efficiency.
Digital Health Technologies: Wearable devices and digital health tools for real-time data capture are becoming integral in trials, supporting both remote and hybrid trial models.
Specialized Trials: Growth in oncology and rare disease research, which often require specialized trial designs and complex patient recruitment, is pushing CROs to develop niche expertise.
Patient-Centric Approaches: CROs are focusing on patient-centric methods to enhance participation and retention, especially in studies with rare or hard-to-reach patient populations.
Compliance and Quality Control: As regulations become more stringent, CROs are enhancing their quality assurance programs to ensure compliance with Good Clinical Practice (GCP) and international standards.
Data Security and Privacy: CROs are also adapting to increased demands for data privacy, especially with the rise in remote and decentralized trials.
This report studies the global CRO in Clinical Trials demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRO in Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRO in Clinical Trials that contribute to its increasing demand across many markets.
Sample Report Request CRO in Clinical Trials
https://www.globalinforesearch.com/reports/2366616/cro-in-clinical-trials
Market segment by Type： Phase I Trial、Phase II Trial、Phase III Trial、Phase IV Trial
Market segment by Application：Pharmaceutical、Bio-pharm、Others
Major players covered： Labcorp、IQVIA、Parexel、Syneos Health、PRA Health Sciences、PPD、ICON、Medpace Holdings、Wuxi Apptec、Tigermed、Boji Medical Technology、Pharmaron
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CRO in Clinical Trials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of CRO in Clinical Trials, with price, sales, revenue and global market share of CRO in Clinical Trials from 2019 to 2024.
Chapter 3, the CRO in Clinical Trials competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CRO in Clinical Trials breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and CRO in Clinical Trials market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of CRO in Clinical Trials.
Chapter 14 and 15, to describe CRO in Clinical Trials sales channel, distributors, customers, research findings and conclusion.
Data Sources:
About Us:
GlobaI Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.